CAR T-cell therapy

CAR T-cell therapy has been approved by NICE for adults with diffuse large B-cell lymphoma (DLBCL) or or primary mediastinal large B-cell lymphoma (PMBL) who have had two or more previous courses of treatment but their lymphoma has relapsed (come back) or was refractory (did not respond to treatment) https://lymphoma-action.org.uk/nice-recommends-car-t-cell-therapies-lymphoma